Skip to main content
Sponsored

Patient-derived organoids are de-risking clinical drug development

Biotechnology company merges with a leading global life science and technology company to enhance its offering of patient-derived organoid services for clinical drug development. Drug development is a long, costly and high-risk process, often taking upwards of 10–15 years, and typically costing over £1 billion for each new therapy. Drug candidate attrition rates Despite significant … Continued
Clinical Trials Q2 2022

Public involvement in research leads to a better experience for all

Clinical research shouldn’t just be shaped by the researchers conducting it – the voices of patients, carers and other members of the public are vital. A variety of voices involved in clinical research makes the clinical trial experience a better one for all, with richer results, drawing on patients’ experience and knowledge of what is … Continued
Sponsored

Rethinking data quality best practice in the era of decentralised clinical trials

Pandemic-related disruptions have accelerated much-needed change in clinical operations, but this change has been accompanied by questions about data collection and data quality.  In a recent survey commissioned by Oracle Health Sciences, more than 75% of industry respondents indicated that limitations in patients’ ability to attend on-site visits sped up their adoption of decentralised clinical trial … Continued